PTK2 and hepatocellular carcinoma: Our study substantiated that overexpression of DARS-AS1 amplified the malignant phenotypes of HCC cells, up-regulated CKAP2 and activated the focal adhesion kinase (FAK)-extracellular signal-regulated kinase (ERK) pathway.